Story perspectives

GeneDx Launches Program to Boost Autism Genetic Testing

10/10/2025

37 8

Summary

Story summary

GeneDx's Autism Partnership Program aims to enhance access to genetic testing for SHANK3-related autism and Phelan-McDermid syndrome.
Recent studies analyze factors contributing to increased autism diagnoses, utilizing genetic data from over 2 million individuals and examining dietary impacts.
These research efforts align with GeneDx's initiative to improve autism research and care.
The program, backed by Jaguar Gene Therapy, seeks to raise the current genetic diagnosis rate of 16% for children with autism.

1 of 1

Story summary

GeneDx's Autism Partnership Program aims to enhance access to genetic testing for SHANK3-related autism and Phelan-McDermid syndrome.
Recent studies analyze factors contributing to increased autism diagnoses, utilizing genetic data from over 2 million individuals and examining dietary impacts.
These research efforts align with GeneDx's initiative to improve autism research and care.
The program, backed by Jaguar Gene Therapy, seeks to raise the current genetic diagnosis rate of 16% for children with autism.